Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells
about
Interleukin 12 deficiency associated with recurrent infectionsCharged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin-12UVB induces IL-12 transcription in human keratinocytes in vivo and in vitroEpstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietinA functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunitsProduction of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cellsCoexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factorLocal production of the p40 subunit of interleukin 12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejectionThe interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cellsStimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha productionInterleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cellsInterleukin 12: still a promising candidate for tumor immunotherapy?Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytesDifferential associations between the cytoplasmic regions of the interleukin-12 receptor subunits beta1 and beta2 and JAK kinasesSystematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cellsExogenous type-1 cytokines modulate mercury-induced hyper-IgE in the ratSwitch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and PentostamLeishmania donovani triose phosphate isomerase: a potential vaccine target against visceral leishmaniasisEfficient production and purification of recombinant human interleukin-12 (IL-12) overexpressed in mammalian cells without affinity tagTumor Therapy Applying Membrane-bound Form of Cytokines.The toxicology of interleukin-12: a review.In vivo regulation of replicative Legionella pneumophila lung infection by endogenous interleukin-12.Measurement of cytokines in clinical samples using immunoassays: problems and pitfalls.Depressed interleukin-12 (IL-12), but not IL-18, production in response to a 30- or 32-kilodalton mycobacterial antigen in patients with active pulmonary tuberculosisCruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice.Interleukin 12 at the site of disease in tuberculosis.Interleukin-12: an update on its immunological activities, signaling and regulation of gene expressionOcular infection of mice with an avirulent recombinant HSV-1 expressing IL-4 and an attenuated HSV-1 strain generates virulent recombinants in vivo.Purification of a factor which provides a costimulatory signal for gamma interferon productionInfluence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma.Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma.IL-12/IL-2 combination cytokine therapy for solid tumours: translation from bench to bedside.Lactobacillus gasseri OLL2809 is effective especially on the menstrual pain and dysmenorrhea in endometriosis patients: randomized, double-blind, placebo-controlled study.Gastric epithelial expression of IL-12 cytokine family in Helicobacter pylori infection in human: is it head or tail of the coin?RNA-sequence analysis of human B-cells.IL12Rβ1: the cytokine receptor that we used to know.Adding cytokines to monoclonal antibody therapy: does the concurrent administration of interleukin-12 add to the efficacy of rituximab in B-cell non-hodgkin lymphoma?In vivo induction of interleukin-12 mRNA expression after oral immunization with Salmonella dublin or the B subunit of Escherichia coli heat-labile enterotoxin.Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublinInterleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes
P2860
Q22004017-98F2C239-A44E-46EC-A143-F545A92C38DFQ22254620-A7E2CC4E-4C87-4EA3-9EDB-DAF40A3BF030Q24312131-D094591E-1236-4792-A893-A525B98EBAFCQ24320304-BA0D1228-0269-407F-9B36-A6C041C11C77Q24323368-1D13D230-21C9-4C62-A7D7-B09166F15284Q24338274-54719CCB-7B92-4971-B1D9-C5817B727935Q24338518-EC2A4520-E255-4970-80F9-18B5DE9E5355Q24630780-DA5CC54B-4002-4A35-8B9E-C6C582452680Q24678409-0F8D9736-35A9-4CA1-8080-F32F7D48DCD9Q24679477-2DE92FD1-CA70-4812-B9CD-162953DFC9C3Q24679768-B8768F07-8F73-406A-94F5-5CDAF7CE7479Q26861559-240743D6-0C33-4C72-BB3D-F94AAA309729Q28295404-D9945FD5-FA3E-4504-9C0C-1F1B40B87870Q28303959-C29DA3F7-05F4-43B5-A0BA-DE9A057F2293Q28343871-419A8C09-81F2-49E5-B171-97F4F9B6CB0CQ28344428-944D3E7E-A64F-4077-A65E-86F6E829AE2CQ28368077-8F65E7F6-415C-4266-92D3-B0EABCDB8590Q28483976-CD02D0A4-D848-4B23-9AA2-19B9E89B3268Q28655742-EC6302A7-2EF8-4A5B-8C1D-0F5D44C03A67Q33631960-5CA1853C-C07B-4FEB-8F43-45891A491A33Q33657643-6FC9CA47-0172-4403-93F0-E37CF34EEDCEQ33747346-2CAF5740-B166-46D8-A084-8A2DB3C8CF53Q33918736-87257FD7-A00C-42F5-8338-11F1637F87B4Q34007624-C40C1BDA-3688-421C-8EC6-2C9629FB6015Q34130172-B7DED53E-24CD-49DB-9F48-D497B58B7403Q34140928-FE520DE8-C08E-42EF-A6A5-2F3306B05EB7Q34248780-70EB76EB-87A9-4864-9C48-DDDDA0B11642Q34364070-04708012-B5FE-4E33-9DC3-56C8077A86CAQ34520652-D78D257A-81FD-4EB2-8762-A0B0B86C4E45Q34577679-57EAD765-10C7-4F45-80DE-3398880CE976Q34667171-0FA91E48-4524-4D35-B942-B31EA463CC42Q34701390-433786F4-F428-42C5-85F5-CB3EA8E8CB82Q34827788-7F9C665E-1F88-4E6B-AABB-4F43EDFB8E37Q34999507-80C71D18-C4A3-4F48-BC93-CEA2241F87BBQ35020163-6DEC6ADA-53E0-438B-9E3B-27E5A3E9C409Q35136546-321E8EAF-34BD-4C70-8279-7875E3696E74Q35210415-50CB476F-44AD-46DB-BA3F-C29267CE6D19Q35395310-CDCCFC9C-8D42-4377-933E-4184E2D153F2Q35484698-8A2EF4D4-74AF-47B1-AC16-A52C4D293D6AQ35494931-B6B0B93E-24BC-4EF1-8EA0-2C6226C46F3A
P2860
Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells
description
1990 nî lūn-bûn
@nan
1990 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Purification to homogeneity an ...... m human B-lymphoblastoid cells
@ast
Purification to homogeneity an ...... m human B-lymphoblastoid cells
@en
Purification to homogeneity an ...... m human B-lymphoblastoid cells
@en-gb
Purification to homogeneity an ...... m human B-lymphoblastoid cells
@nl
type
label
Purification to homogeneity an ...... m human B-lymphoblastoid cells
@ast
Purification to homogeneity an ...... m human B-lymphoblastoid cells
@en
Purification to homogeneity an ...... m human B-lymphoblastoid cells
@en-gb
Purification to homogeneity an ...... m human B-lymphoblastoid cells
@nl
prefLabel
Purification to homogeneity an ...... m human B-lymphoblastoid cells
@ast
Purification to homogeneity an ...... m human B-lymphoblastoid cells
@en
Purification to homogeneity an ...... m human B-lymphoblastoid cells
@en-gb
Purification to homogeneity an ...... m human B-lymphoblastoid cells
@nl
P2093
P2860
P921
P3181
P356
P1476
Purification to homogeneity an ...... m human B-lymphoblastoid cells
@en
P2093
A G Wolitzky
D L Stremlo
F J Podlaski
J D Hulmes
P C Familletti
R Chizzonite
P2860
P304
P3181
P356
10.1073/PNAS.87.17.6808
P407
P577
1990-09-01T00:00:00Z